Arteriocyte is now a part of Isto Biologics.

The News and Views of Isto

Innovation can move quickly, and we want you to be a part of it. Stay up to date with our latest actions in bone regeneration and autologous cell therapy.

Novel and Noteworthy

Building attention through advancement.

Every day, Isto scientists, researchers, innovators, and leaders work to create breakthroughs — newsworthy contributions for the healthcare and scientific communities that continue to count on us and our technologies. It’s a responsibility we’ve tasked ourselves with, and it’s one that we take very seriously. Every innovation, every advancement, creates news; but more importantly, it creates opportunities for improving healthcare.

Dr. Rodriguez discusses treatment options with course attendees.

Isto Biologics Sponsors Preceptorship on Autologous Therapy in Lower Extremity Orthopedics and Neurologic Procedures

Isto Biologics’ Medical Education team recently supported a biologics Hospital-Based Observation Preceptorship led by Dr. Edgardo Rodriguez, DPM. Course attendees were educated on autologous therapy using the Magellan® Autologous Concentration […]

Read More

Isto Biologics Acquires Progenicare and Expands Its Clinically-Focused Service Model

Isto Holdings, the parent company of St. Louis-based Isto Biologics has acquired Progenicare, a national medical sales and service company. As a leader in bone regeneration and cell-based therapies, Isto […]

Read More

To top